Literature DB >> 31975964

Cannabis and the Current State of Treatment for Cannabis Use Disorder.

Arthur Robin Williams1, Kevin P Hill1.   

Abstract

Although the opioid epidemic may command more national headlines, the past two decades have seen a revolution in cannabis policy driven largely by the public and by business interests. As a result, the population of cannabis users nationwide-especially of heavy users-has grown yearly. Although less visible than patients admitted to the emergency department for opioid-related overdose or to treatment for opioid use disorder, an estimated 4.5-7 million individuals in the United States are thought to meet criteria for cannabis use disorder in a given year. This article focuses on the developmental pathways of cannabis use disorder, the epidemiology of cannabis use among adolescents and adults in the context of rapidly changing state laws, and evidence-based treatment for the general psychiatrist. The authors provide an overview of pharmacological and psychosocial behavioral treatments for patients with the disorder while emphasizing aspects of clinical management unique to this patient population.
Copyright © by the American Psychiatric Association.

Entities:  

Year:  2019        PMID: 31975964      PMCID: PMC6527009          DOI: 10.1176/appi.focus.20180038

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  20 in total

1.  Abstinence symptoms following smoked marijuana in humans.

Authors:  M Haney; A S Ward; S D Comer; R W Foltin; M W Fischman
Journal:  Psychopharmacology (Berl)       Date:  1999-02       Impact factor: 4.530

Review 2.  The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal.

Authors:  Christina A Brezing; Frances R Levin
Journal:  Neuropsychopharmacology       Date:  2017-09-06       Impact factor: 7.853

3.  Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.

Authors:  Kevin P Hill; Matthew D Palastro; Staci A Gruber; Garrett M Fitzmaurice; Shelly F Greenfield; Scott E Lukas; Roger D Weiss
Journal:  Am J Addict       Date:  2017-09-18

4.  Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  Catalina Lopez-Quintero; José Pérez de los Cobos; Deborah S Hasin; Mayumi Okuda; Shuai Wang; Bridget F Grant; Carlos Blanco
Journal:  Drug Alcohol Depend       Date:  2010-12-08       Impact factor: 4.492

5.  Older, Less Regulated Medical Marijuana Programs Have Much Greater Enrollment Rates Than Newer 'Medicalized' Programs.

Authors:  Arthur Robin Williams; Mark Olfson; June H Kim; Silvia S Martins; Herbert D Kleber
Journal:  Health Aff (Millwood)       Date:  2016-03       Impact factor: 6.301

6.  Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana.

Authors:  Joseph J Palamar; Michael Fenstermaker; Dimita Kamboukos; Danielle C Ompad; Charles M Cleland; Michael Weitzman
Journal:  Am J Drug Alcohol Abuse       Date:  2014-08-29       Impact factor: 3.829

7.  Towards a comprehensive developmental model of cannabis use disorders.

Authors:  Carlos Blanco; Claudia Rafful; Melanie M Wall; Ty A Ridenour; Shuai Wang; Kenneth S Kendler
Journal:  Addiction       Date:  2013-11-21       Impact factor: 6.526

8.  Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis.

Authors:  J Cobb Scott; Samantha T Slomiak; Jason D Jones; Adon F G Rosen; Tyler M Moore; Ruben C Gur
Journal:  JAMA Psychiatry       Date:  2018-06-01       Impact factor: 21.596

9.  Pharmacological interventions in the treatment of the acute effects of cannabis: a systematic review of literature.

Authors:  José As Crippa; Guilherme N Derenusson; Marcos Hn Chagas; Zerrin Atakan; Rocio Martín-Santos; Antonio W Zuardi; Jaime Ec Hallak
Journal:  Harm Reduct J       Date:  2012-01-25

10.  Insights from individuals successfully recovered from cannabis use disorder: natural versus treatment-assisted recoveries and abstinent versus moderation outcomes.

Authors:  David C Hodgins; Jonathan N Stea
Journal:  Addict Sci Clin Pract       Date:  2018-07-30
View more
  5 in total

1.  Cannabis as a Gateway Drug for Opioid Use Disorder.

Authors:  Arthur Robin Williams
Journal:  J Law Med Ethics       Date:  2020-06       Impact factor: 1.718

2.  Progress and Future: Meeting the Needs of the Nation's Substance Use Crisis.

Authors:  Justine W Welsh; Joji Suzuki
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-04-10

Review 3.  Care of the Patient Using Cannabis.

Authors:  Arthur Robin Williams; Kevin P Hill
Journal:  Ann Intern Med       Date:  2020-11-03       Impact factor: 25.391

4.  Psychosocial and health problems associated with alcohol use disorder and cannabis use disorder in U.S. adults.

Authors:  Sarah Gutkind; David S Fink; Dvora Shmulewitz; Malka Stohl; Deborah Hasin
Journal:  Drug Alcohol Depend       Date:  2021-10-28       Impact factor: 4.492

Review 5.  Workplace Cannabis Policies: A Moving Target.

Authors:  Mia C Hazle; Kevin P Hill; Laurence M Westreich
Journal:  Cannabis Cannabinoid Res       Date:  2020-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.